Tirzepatide 30mg

Tirzepatide 30mg is a dual agonist peptide studied for its interaction with metabolic regulatory pathways.

Research Overview
Tirzepatide has been widely examined in laboratory settings for its activity on GLP-1 and GIP receptors, making it a subject of interest in metabolic and endocrine research.

Key Characteristics

• Dual incretin receptor agonist
• Studied in metabolic pathway research
• Investigated for glucose regulation signaling

Specifications

• 3ml multi-use vial
• Lyophilized powder
• Purity ≥99%
• Third-party tested

For research purposes only. Not for human consumption. This product is intended solely for use in laboratory and scientific research settings. RR Peptides does not condone the use of this product outside of a controlled research environment.